The 46th The Korean Society of Nonclinical Study (KSNS) Workshop

The 46^th The Korean Society of Nonclinical Study (KSNS) Workshop is only two weeks to go! Medicilon is excited to exhibit in the conference. Dr. Hanjun Zou, TFM of Medicilon Chuansha site, and Medicilon KoreanTeam will be available at Medicilon Booth #43. Dr. Zou has more than 17 years of experience in toxicity and preclinical safety assessment with most career working in multinational companies. Dr. Zou is also a certified toxicologist (DCST, ERT & DABT) in China, Europe and the United States.

We are getting ready. Are you?

Date: October 17-18, 2024

Location: Gyeongju, South Gyeongsang Province

Medicilon Booth #43

Medicilon

Medicilon is a leading global integrated pharmaceutical R&D service contract research organization (CRO), providing a full range of one-stop preclinical R&D services, in compliance with Chinese and international regulatory filing standards, to pharmaceutical companies and research institutions world-wide. With our experience in serving domestic and foreign biomedical industries, we have built an integrated platform covering key technologies in drug discovery, pharmaceutical research, and preclinical research, to provide a comprehensive preclinical R&D service for the global biomedical industry.

20 Years of Excellence

500+ IND Approved by FDA, NMPA, EMA, and TGA

2000+ Active Clients Worldwide

2600+ Scientists & Research Staff

85,000+ m² Lab Space

At Medicilon, we are dedicated to support our clients develop their research and discovery programs from initial concept through the IND filing phase. Our services span across medicinal chemistry, biology, API, CMC, formulation, and preclinical studies. We provide flexible business models, including stand-alone Fee for Services (FFS) and fully integrated FTE services. In addition, our facilities are GLP/GMP compliant, US-FDA, China NMPA and AAALAC accredited. All study reports can be presented in SEND format, supporting dual filing of IND applications in the US, EU, and China.

Medicilon Preclinical Research Services

Medicilon's state-of-the-art preclinical facilities hold full AAALAC accreditation. With advanced platforms and experienced scientists, Medicilon guarantees the utmost professionalism in drug efficacy and safety assessments services, adhering to global regulatory standards. Offering services from stand-alone preclinical studies to comprehensive IND-enabling packages, Medicilon provides flexible solutions to efficiently support biotech and pharmaceutical clients in reaching their developmental milestones.

Medicilon's Preclinical Research Division services include the following for small molecules, biologics and medicinal herbs: Pharmacology, Pharmacodynamics, ADME,DMPK, Bioanalysis, Drug Safety Evaluation. Medicilon maintains a large in-house library of animal disease models to meet the research demands in different therapeutic areas.  Medicilon can also assist clients in the preparation of a preclinical safety evaluation package.

Pharmacology 

❖Tumor Animal Models (400+) 

❖Non-tumor Animal Models (270+)

DMPK & BIOANALYSIS 

❖In Vitro ADMET 

❖In Vivo PK & Tox

Preclinical Safety Assessment (GLP & non-GLP) 

❖Single and repeated-dose toxicity studies 

❖Reproductive/developmental and juvenile toxicity studies 

❖Genotoxicity studies 

❖Toxicokinetic studies 

❖Safety pharmacology research 

❖Immunogenicity studies 

❖Local tolerance studies 

❖Carcinogenicity studies

Meet with Medicilon

Subject丨46th KSNS

Company *

Name *

Work Email *

Title*

Verification Code